2025年1月2日 · Natco Pharma is a leading pharmaceutical company specializing in oncology, generic medications, and innovative solutions for crop health. Discover their high-quality healthcare products.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. [5] It is a major producer of branded oncology medicines [6] cardiology, diabetology and other pharma specialty drugs. [7]

1 天前 · Natco Pharma share price slumped nearly 19% on Thursday, in an otherwise positive broader market, after the Hyderabad-based drug maker as investors weighed weak December quarter earnings. The smallcap pharma stock has under floating in negative terrain for the last five sessions, eroding nearly 26% of its market value.

1 天前 · NATCO Pharma share price performance: On Wednesday, NATCO Pharma shares closed at Rs 1,216.6, down 2% on the BSE, while the benchmark Sensex declined 0.16%. The stock has declined 18% over the past six months but gained 131% in the last two years. The company’s market capitalization stands at Rs 21,791 crore.

1 天前 · Natco Pharma share price tanked 19 per cent to Rs 986 on the BSE in Thursday’s intra-day trade amid heavy volumes after the company reported a weak set of numbers in its December 2024 quarter (Q3FY25) results. Consolidated profit after tax (PAT) declined 37.8 per cent year-on-year (YoY), at Rs 132.40 crore.

1 天前 · Shares of NATCO Pharma tumbled 19% on Thursday, February 13, following the announcement of its results for the third quarter of fiscal 2024-25 (Q3 FY25), wherein it posted a decline in revenue ...

1 天前 · Natco was at the bottom of the index and was one of just two stocks in the index that was in the red. The other one was Gland Pharma Ltd which had its shares drop 0.09%, reaching ₹ 1,477.45.